The Effect of BMI on Gluteus Maximum Activity in Adulthood With Sacroiliac Dysfunction

June 2, 2024 updated by: Mohamed Ababa, Ahram Canadian University

PURPOSE:

This study will be conducted to investigate the effect of BMI on gluteus maximum activity in adulthood with sacroiliac dysfunction BACKGROUND: Sacroiliac joint (SIJ) pain is pain arising from SIJ structures and SIJ dysfunction (SIJD) generally refers to aberrant position or movement of SIJ structures . An estimated 15-30% of all low back pain cases are due to SIJ pain The present study will be conducted to add a new information to the body of knowledge of physical therapy profession as it will investigate the effect of BMI on gluteus maximum activity in adulthood with sacroiliac dysfunction

HYPOTHESES:

. •There will be no effect of BMI on gluteus maximum activity in adulthood with sacroiliac dysfunction

RESEARCH QUESTION:

  • Do BMI has an effect on gluteus maximum activity in adulthood with sacroiliac dysfunction?

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Giza, Egypt, 12573
        • Recruiting
        • Ahram Canadian University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Subjects:

A total of 60 male & female subjects, diagnosed with sacroiliac dysfunction participated in this study. Their BMI will from 20- 30kg/m2.

Description

Inclusion Criteria:

- adulthood with sacroiliac dysfunction

  • Their ages will range from 20-40 years old.
  • Their BMI will be less than 20- 30kg/m2.
  • All of them suffer from mild to moderate degree of sacroiliac pain.
  • The subjects complain from sacroiliac pain for 1 month ago

Exclusion Criteria:

  • Exclusion criteria were a history of any of the following condition:

    • inflammatory diseases or any rheumatic disorders,
    • a history of vertebral fractures
    • surgical spinal fixation.
    • •any neurological disorders like MS

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group (A):
o Group (A): will includes subjects with sacroiliac dysfunction and their body mass index < 25
Diagnostic test: Electromyography (EMG)
The present study will be conducted to add a new information to the body of knowledge of physical therapy profession as it will investigate the effect of BMI on gluteus maximum activity recorded by EMG in adulthood with sacroiliac dysfunction
Group (B):
o Group (B): will includes subjects with sacroiliac dysfunction and their body mass index > 25.
Diagnostic test: Electromyography (EMG)
The present study will be conducted to add a new information to the body of knowledge of physical therapy profession as it will investigate the effect of BMI on gluteus maximum activity recorded by EMG in adulthood with sacroiliac dysfunction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
gluteus maximum muscle activity measured by Electromyography (EMG)
Time Frame: up to 8 weeks
up to 8 weeks
weight and height will be combined to report BMI in kg/m^2)
Time Frame: up to 8 weeks
up to 8 weeks
visual analogue scale for pain
Time Frame: up to 8 weeks
up to 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ahram Canadian University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 12, 2024

Primary Completion (Estimated)

June 20, 2024

Study Completion (Estimated)

June 30, 2024

Study Registration Dates

First Submitted

May 13, 2024

First Submitted That Met QC Criteria

June 2, 2024

First Posted (Estimated)

June 4, 2024

Study Record Updates

Last Update Posted (Estimated)

June 4, 2024

Last Update Submitted That Met QC Criteria

June 2, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T-REC-012/005149

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe